Characteristics | Adolescents N = 65 | Young adults N = 818 | p-value |
---|---|---|---|
Transferred-in patients, n (%) | 19 (29.2) | 103 (12.6) | Â |
Female, n (%) | 43 (66.2) | 708 (86.6) | < 0.0001 |
CD4†(cells/μL), median (IQR) | 133.5 (41-198) | 116 (56-170) | 0.31 |
Baseline viral load** (copies/ml), log10 median IQR) | 4.8 (4.5-5.2) | 4.8 (4.4-5.3) | 0.74 |
ART regimen at cohort entry, n (%) | Â | Â | Â |
EFV-based | 53 (81.5) | 413 (50.5) | < 0.001 |
NVP-based | 11 (16.9) | 396 (48.4) | Â |
PI-based | 1 (1.5) | 9 (1.1) | Â |